Clinical Trial Applications: Filter, Search, and view applications


Clear
Extended search...

Page 19 of 38, showing 5 Applications out of 189 total, starting on record 91, ending on 95

# Protocol No Study Title Investigator(s) & Site(s)

91.

ECCT/21/11/01   VAT 00008
    A parallel-group, Phase III, multi-stage, modified double-blind, multi-armed study to assess the efficacy, safety, and immunogenicity of two SARS-CoV-2 Adjuvanted Recombinant Protein Vaccines (monovalent and bivalent) for prevention against COVID-19 in adults 18 years of age and older   
Principal Investigator(s)
1. Walter Godfrey Jaoko
Site(s) in Kenya
1. Kenya Medical Research Institute (Kisumu county)
2. KEMRI/Walter Reed Project Research Center (Kericho county)
3. KEMRI/CCR Partners in Health R&D (PHRD) (Kiambu county)
4. KEMRI CMR (Kisumu county)
5. Kenya Medical Research Institute (Nairobi City county)
6. KEMRI-UAMRD-A/K, Kombewa Clinical Research Center (Kisumu county)
7. Moi University Clinical Research Centre (Uasin Gishu county)
8. Aga Khan University Hospital (Nairobi City county)
9. KEMRI CCR-Butere County Hospital Site (Kakamega county)
10. Ganjoni Clinic (Mombasa county)
 
View

92.

ECCT/21/10/05   Lactolize Study
    Lactoferrin and Lysozyme supplementation for long-term diarrhea sequelae   
Principal Investigator(s)
1. Benson Ochieng Singa
Site(s) in Kenya
1. Awendo Sub-County Hospital (Migori county)
2. Homa Bay County Referral Hospital (Homa Bay county)
3. Isebania Sub-County Hospital (Migori county)
4. Kendu Adventist Hospital (Homa Bay county)
5. Kisii Teaching and Referral Hospital (Kisii county)
6. Mbita Sub-County Hospital (Homa Bay county)
7. Rongo Sub-County Hospital (Migori county)
 
View

93.

ECCT/21/09/08   GBT133_Inclacumab Open-Label
    An Open-Label Extension Study to Evaluate the Long-Term Safety of Inclacumab Administered to Participants with Sickle Cell Disease Who Have Participated in an Inclacumab Clinical Trial   
Principal Investigator(s)
1. Fredrick Sirwa Chite
2. Bernhards Ragama Ogutu
3. Videlis N Nduba
4. Prof Jessie N Githanga
Site(s) in Kenya
1. International Cancer Institute (ICI)-Eldorate (Uasin Gishu county)
2. KEMRI/CRDR (Nairobi City county)
3. KEMRI Siaya Clinical Research Annex (Siaya county)
4. Gertrude’s Children’s Hospital. (Nairobi City county)
5. Strathmore University Medical Centre (Nairobi City county)
 
View

94.

ECCT/21/09/04   Recombinant COVID-19 Vaccine
    A global multicenter, randomized, double-blind, placebo-controlled, phase III clinical trial to evaluate the efficacy, safety, and immunogenicity of recombinant COVID-19 vaccine (Sf9 cells) for the prevention of COVID-19 in adults aged 18 years and older            
Principal Investigator(s)
1. Sylvester Kimaiyo
Site(s) in Kenya
1. KAVI-Institute of Clinical Research (Nairobi City county)
2. Moi Teaching and Referral Hospital (Uasin Gishu county)
3. Kenya Medical Research Institute, Kilifi (Kilifi county)
 
View

95.

ECCT/21/09/01   Kuwa Free! - Live free!
    Co-benefits of co-delivery of long-acting antiretrovirals and contraceptives   
Principal Investigator(s)
1. Rena Patel
2. Edwin Were
Site(s) in Kenya
Moi Teaching and Referral Hospital
 
View